Phibro Animal Health (NASDAQ:PAHC) Raised to Buy at BidaskClub

Phibro Animal Health (NASDAQ:PAHC) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday, June 26th, BidAskClub reports.

A number of other equities analysts have also recently commented on PAHC. Barclays reiterated a “hold” rating on shares of Bank of Montreal in a report on Tuesday, June 11th. ValuEngine downgraded shares of Verso from a “hold” rating to a “sell” rating in a research report on Thursday, May 23rd. Guggenheim reiterated a “buy” rating and issued a $95.00 price target (up from $90.00) on shares of VF in a research report on Thursday, May 23rd. Zacks Investment Research upgraded shares of Triple-S Management from a “hold” rating to a “buy” rating and set a $26.00 price target for the company in a research report on Monday, April 29th. Finally, Gabelli upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price target for the company in a research report on Wednesday, May 8th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $41.50.

PAHC stock traded up $0.42 during trading hours on Wednesday, reaching $30.39. 62,746 shares of the stock were exchanged, compared to its average volume of 164,903. The firm’s 50-day simple moving average is $30.41. The company has a market cap of $1.23 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 4.26 and a beta of 0.74. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41. Phibro Animal Health has a 12 month low of $27.32 and a 12 month high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.39 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a net margin of 8.12% and a return on equity of 33.77%. The company had revenue of $205.70 million during the quarter, compared to the consensus estimate of $214.94 million. During the same quarter in the previous year, the business earned $0.46 EPS. Phibro Animal Health’s revenue was down 1.5% on a year-over-year basis. Equities analysts expect that Phibro Animal Health will post 1.52 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Advisors Asset Management Inc. lifted its position in Phibro Animal Health by 52.3% during the fourth quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock worth $82,000 after acquiring an additional 871 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Phibro Animal Health by 19.9% in the 4th quarter. Rhumbline Advisers now owns 58,359 shares of the company’s stock worth $1,877,000 after acquiring an additional 9,699 shares during the last quarter. Victory Capital Management Inc. grew its position in Phibro Animal Health by 4.1% in the 4th quarter. Victory Capital Management Inc. now owns 10,756 shares of the company’s stock worth $346,000 after purchasing an additional 419 shares in the last quarter. Oregon Public Employees Retirement Fund bought a new position in shares of Phibro Animal Health during the 4th quarter valued at approximately $247,000. Finally, California Public Employees Retirement System grew its position in shares of Phibro Animal Health by 34.5% during the 4th quarter. California Public Employees Retirement System now owns 46,524 shares of the company’s stock valued at $1,496,000 after acquiring an additional 11,939 shares during the period. Hedge funds and other institutional investors own 50.28% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Read More: Compound Annual Growth Rate (CAGR)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.